Correlation Between Saia and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Saia and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Saia and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Saia Inc and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Saia and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Saia with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Saia and Mineralys Therapeutics,.
Diversification Opportunities for Saia and Mineralys Therapeutics,
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Saia and Mineralys is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Saia Inc and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Saia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Saia Inc are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Saia i.e., Saia and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Saia and Mineralys Therapeutics,
Given the investment horizon of 90 days Saia Inc is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Saia Inc is 2.42 times less risky than Mineralys Therapeutics,. The stock trades about -0.1 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,338 in Mineralys Therapeutics, Common on September 13, 2024 and sell it today you would lose (43.00) from holding Mineralys Therapeutics, Common or give up 3.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Saia Inc vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Saia Inc |
| Mineralys Therapeutics, |
Saia and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Saia and Mineralys Therapeutics,
The main advantage of trading using opposite Saia and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Saia position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.The idea behind Saia Inc and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Mineralys Therapeutics, vs. Puma Biotechnology | Mineralys Therapeutics, vs. Iovance Biotherapeutics | Mineralys Therapeutics, vs. Sarepta Therapeutics | Mineralys Therapeutics, vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |